Repros Therapeutics, Inc. (RPRX) Posts Wider than Expected Q2 Loss of 21c/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.52 +0.14%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Bernstein SocGen Group Starts Amphenol (APH) at Outperform
- Talos Energy closes $420M Gulf of America deepwater asset deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
